glp-1 release Agonists: Increasing Effective Insulin Science Behind GLP 1 GIP
Description
Personalized Support to Reach your Goals
What can sleep physicians do when obstructive sleep apnea patients can't afford every recommended therapy, like CPAP and GLP-1s?
Access quality care anytime, anywhere with FIG Health.
How to Use
Lilly announced the topline results from its phase 3b "TOGETHER PsA" trial, showing that the combination use of ixekizumab (Taltz) and tirzepatide (Zepbound) was superior to IXE alone, yielding both significant weight loss and ACR50 disease control in adults with active psoriatic arthritis (PsA).
